In Ireland, WuXi NextCODE Embarks on Unprecedented Effort to Enable Precision Medicine at National Scale, with Global Impact
Centerpiece of this effort is the acquisition of Genomics Medicine Ireland (GMI) as WXNC's Irish subsidiary, part of $400m in Ireland precision medicine investments announced today.